Related Experiment Video
Updated: Aug 19, 2026

Identification of MyoD Interactome Using Tandem Affinity Purification Coupled to Mass Spectrometry
Published on: May 17, 2016
Transcriptional activation of bovine mimecan by p53 through an intronic DNA-binding site
E S Tasheva1, C G Maki, A H Conrad
1Division of Biology, Kansas State University, Manhattan 66506-4901, USA. est@ksu.edu
Abstract:
Mimecan is a small leucine-rich proteoglycan that can occur as either keratan sulfate proteoglycan in the cornea or as glycoprotein in many connective tissues. As yet, there is no information on its transcriptional regulation. Recently we demonstrated the presence of eight mimecan mRNA transcripts generated by alternative transcription initiation, alternative polyadenylation, and differential splicing, all of which encode an identical protein. Here we report a conserved consensus p53-binding DNA sequence in the first intron of bovine and human mimecan genes and show that wild-type p53 binds to this sequence in vitro. Co-transfections of Saos-2, HeLa, NIH 3T3, and primary bovine corneal keratocytes with bovine mimecan promoter/luciferase reporter constructs in combination with p53 expression vectors activate the second mimecan promoter through the p53-binding sequence. In addition, we show absence of mimecan expression in different tumors and cancer cell lines, where p53 frequently is inactivated/mutated. Thus, this work provides novel information that links mimecan to the p53 network.
Insights
This study reveals that the mimecan gene is regulated by the p53 protein. Mimecan expression is reduced in tumors, suggesting a role for mimecan in cancer, linked to the p53 network.
Area of Science:
- Molecular Biology
- Gene Regulation
- Cancer Biology
Background:
- Mimecan, a small leucine-rich proteoglycan, exists as a keratan sulfate proteoglycan or glycoprotein.
- Transcriptional regulation of mimecan was previously unknown.
- Eight mimecan mRNA transcripts, encoding a single protein, are generated through alternative RNA processing.
Purpose of the Study:
- To investigate the transcriptional regulation of the mimecan gene.
- To determine the relationship between mimecan and the p53 tumor suppressor network.
Main Methods:
- Identified a conserved p53-binding DNA sequence in the first intron of human and bovine mimecan genes.
- Performed in vitro binding assays with wild-type p53 and mimecan DNA sequence.
- Utilized co-transfection assays with mimecan promoter-luciferase constructs and p53 expression vectors in various cell lines.
Main Results:
- Wild-type p53 demonstrated binding to the identified consensus sequence in vitro.
- Co-transfection experiments showed activation of the mimecan promoter via the p53-binding sequence.
- Mimecan expression was found to be absent in multiple tumor types and cancer cell lines with inactivated p53.
Conclusions:
- This study establishes a novel link between mimecan and the p53 regulatory network.
- The findings suggest that mimecan may function as a tumor suppressor gene regulated by p53.
- Further research into mimecan's role in cancer biology is warranted.
Related Concept Videos
Epigenetic Regulation
RNA Polymerase II Accessory Proteins
Master Transcription Regulators
Genomic Imprinting and Inheritance
The expression of some genes depends on which parent passed the gene to the offspring, through a phenomenon known as...
Abnormal Proliferation
Epigenetic Regulation
X-chromosome...

